AR115756A1 - TGFb1 INHIBITORS AND USE OF THEM - Google Patents

TGFb1 INHIBITORS AND USE OF THEM

Info

Publication number
AR115756A1
AR115756A1 ARP190101956A ARP190101956A AR115756A1 AR 115756 A1 AR115756 A1 AR 115756A1 AR P190101956 A ARP190101956 A AR P190101956A AR P190101956 A ARP190101956 A AR P190101956A AR 115756 A1 AR115756 A1 AR 115756A1
Authority
AR
Argentina
Prior art keywords
tgfb1
inhibitors
antigen
methods
monoclonal antibodies
Prior art date
Application number
ARP190101956A
Other languages
Spanish (es)
Inventor
Justin W Jackson
Susan Lin
Kevin B Dagbay
Gregory J Carven
Christopher Littlefield
Christopher Chapron
Stefan Wawersik
Allan Capili
Thomas Schurpf
Abhishek Datta
Original Assignee
Scholar Rock Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scholar Rock Inc filed Critical Scholar Rock Inc
Publication of AR115756A1 publication Critical patent/AR115756A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

En el presente documento se describen anticuerpos monoclonales y fragmentos de unión a antígeno de los mismos capaces de inhibir selectivamente TGFb1. También se describen composiciones relacionadas, métodos y uso terapéutico.Monoclonal antibodies and antigen-binding fragments thereof capable of selectively inhibiting TGF-1 are described herein. Related compositions, methods, and therapeutic use are also described.

ARP190101956A 2018-07-11 2019-07-11 TGFb1 INHIBITORS AND USE OF THEM AR115756A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862696774P 2018-07-11 2018-07-11

Publications (1)

Publication Number Publication Date
AR115756A1 true AR115756A1 (en) 2021-02-24

Family

ID=74672531

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP190101956A AR115756A1 (en) 2018-07-11 2019-07-11 TGFb1 INHIBITORS AND USE OF THEM

Country Status (1)

Country Link
AR (1) AR115756A1 (en)

Similar Documents

Publication Publication Date Title
CO2021000419A2 (en) Isoform-selective, high-affinity tgfβ1 inhibitors and uses thereof
BR112021024224A2 (en) Tead inhibitors and uses thereof
CL2021001686A1 (en) Single Domain Antibody-Based Chimeric Antigen Receptors and Methods of Using Them (Divisional Application No. 201800378)
BR112021024108A2 (en) Tead inhibitors and uses thereof
CO2020016619A2 (en) Bispecific anti-pvrig / anti-tigit antibodies and methods of use
CO2018010538A2 (en) Specific poliovirus receptor (rvp) antibodies
CO2021001893A2 (en) Anti-gdf15 antibodies, compositions and methods of use
CO2019009373A2 (en) Heterocyclic compounds useful as dual inhibitors of atx / ca.
CO2017000754A2 (en) Anti-ctla4 monoclonal antibody or antigen-binding fragment thereof, and a pharmaceutical composition thereof
CY1125076T1 (en) TGFB1 ISOFORM-SELECTIVE INHIBITORS AND THEIR USE
TR201901445T4 (en) Il2rbeta / common gamma chain antibodies.
EA201992235A1 (en) SYNTHESIS INHIBITOR MCL-1
CL2020002540A1 (en) Anti-hla-g antibodies and their use
WO2020014473A8 (en) TGFβ1 INHIBITORS AND USE THEREOF
CR20160500A (en) ANTI-OX40 ANTIBODIES AND METHODS OF USE
CL2018001722A1 (en) New anti-mfi2 antibodies and methods of use (divisional application 201700506)
CO2021000049A2 (en) Ectonucleotidase inhibitors and methods of using them
AR081750A1 (en) ANTI-CD40 ANTIBODIES
CL2020003083A1 (en) Masp-2 inhibitors and methods of use
CO2020015747A2 (en) Rapamycin analogs and uses thereof
CO2020007895A2 (en) Histone acetyltransferase inhibitors of the myst family
CO2021009129A2 (en) Tubulysins and Protein-Tubulysin Conjugates
CL2021002182A1 (en) Formulation of therapeutic antibodies
UY39798A (en) ANTI-CCR8 ANTIBODIES AND USES THEREOF
BR112022001336A8 (en) BISPECIFIC ANTI-HER2/ANTI-4-1BB ANTIBODY AND USE OF IT